Results 291 to 300 of about 17,630,315 (317)

Expression of the inhibitory checkpoints LAG-3, TIM-3, and PD-1 in NK cells and T cells in acute myeloid leukemia: preserved expression of LAG-3 is associated with patient survival. [PDF]

open access: yesCancer Immunol Immunother
Valhondo I   +14 more
europepmc   +1 more source

Molecular Docking, Molecular Dynamics Simulation, and Pharmacophore-Based Virtual Screening Unveil Natural Compounds with TIM-3 Inhibitory Activity.

open access: yesJ Pharm Bioallied Sci
Alzain AA   +12 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

TIM‐3 Expression in Endometriosis

American Journal of Reproductive Immunology
Endometriosis is a prevalent chronic gynecological disease linked to immune dysfunction. The protein T‐cell immunoglobulin and mucin domain‐containing protein 3 (TIM‐3) plays a crucial role in immune system balance.
José Lourenço Reis   +5 more
semanticscholar   +3 more sources

TIM-3: An update on immunotherapy.

International Immunopharmacology, 2021
T cell immunoglobulin and mucin domain 3 (TIM-3) was originally found to be expressed on the surface of Th1 cells, acting as a negative regulator and binding to the ligand galectin-9 to mediate Th1 cell the apoptosis. Recent studies have shown that TIM-3 is also expressed on other immune cells, such as macrophages, dendritic cells, and monocytes.
Lizhen Zhao   +4 more
semanticscholar   +3 more sources

TIM-3 regulates microglial function

Nature Reviews Drug Discovery
Sarah Crunkhorn
semanticscholar   +2 more sources

Increasing Tim‐3+CD244+, Tim‐3+CD57+, and Tim‐3+PD‐1+ T cells in patients with acute myeloid leukemia

Asia-Pacific Journal of Clinical Oncology, 2020
AbstractAimTo characterize the distribution of T cell immunoglobulin mucin‐domain‐containing‐3 (Tim‐3) within the exhausted T cells in patients with newly diagnosed acute myeloid leukemia (AML) and AML in complete remission.MethodsTim‐3 expression and coexpression with PD‐1, CD244, and CD57 in CD3+, CD4+, and CD8+T cells were analyzed by multicolored ...
Jiaxiong Tan   +7 more
openaire   +2 more sources

Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models

Science Translational Medicine, 2023
T cell immunoglobulin and mucin-containing molecule 3 (Tim-3), expressed in dysfunctional and exhausted T cells, has been widely acknowledged as a promising immune checkpoint target for tumor immunotherapy.
Shuaiya Ma   +26 more
semanticscholar   +1 more source

TIM-3 in autoimmunity

Current Opinion in Immunology, 2006
T cell immunoglobulin and mucin domain (TIM)-3 is a molecule expressed on terminally differentiated murine Th1 cells but not on Th2 cells. Identification of galectin-9 as a ligand for TIM-3 has now firmly established the TIM-3-galectin-9 pathway as an important regulator of Th1 immunity and tolerance induction. TIM-3 is similarly expressed on human Th1
Ana C, Anderson, David E, Anderson
openaire   +2 more sources

Home - About - Disclaimer - Privacy